DE1218454B - Verfahren zur Herstellung von 4-Sulfanilamido-5, 6-dialkoxypyrimidinen - Google Patents

Verfahren zur Herstellung von 4-Sulfanilamido-5, 6-dialkoxypyrimidinen

Info

Publication number
DE1218454B
DE1218454B DEH45758A DEH0045758A DE1218454B DE 1218454 B DE1218454 B DE 1218454B DE H45758 A DEH45758 A DE H45758A DE H0045758 A DEH0045758 A DE H0045758A DE 1218454 B DE1218454 B DE 1218454B
Authority
DE
Germany
Prior art keywords
amino group
sulfanilamido
general formula
group
dialkoxypyrimidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEH45758A
Other languages
German (de)
English (en)
Inventor
Dr Hermann Bretschneider
Dr Wilhelm Kloetzer
Joachim Schantl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE1218454B publication Critical patent/DE1218454B/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DEH45758A 1961-06-16 1962-05-11 Verfahren zur Herstellung von 4-Sulfanilamido-5, 6-dialkoxypyrimidinen Pending DE1218454B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH707361A CH396008A (de) 1961-06-16 1961-06-16 Verfahren zur Herstellung von Sulfonamiden der Pyrimidinreihe

Publications (1)

Publication Number Publication Date
DE1218454B true DE1218454B (de) 1966-06-08

Family

ID=4319495

Family Applications (1)

Application Number Title Priority Date Filing Date
DEH45758A Pending DE1218454B (de) 1961-06-16 1962-05-11 Verfahren zur Herstellung von 4-Sulfanilamido-5, 6-dialkoxypyrimidinen

Country Status (8)

Country Link
US (1) US3132139A (enrdf_load_html_response)
BE (1) BE618639A (enrdf_load_html_response)
CH (1) CH396008A (enrdf_load_html_response)
DE (1) DE1218454B (enrdf_load_html_response)
DK (1) DK98960C (enrdf_load_html_response)
GB (1) GB951026A (enrdf_load_html_response)
NL (1) NL279406A (enrdf_load_html_response)
OA (1) OA00944A (enrdf_load_html_response)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999038376A1 (en) 1998-02-03 1999-08-05 University Of Maryland Method for the stimulation of sperm production and gonadal development in animals
GB0217431D0 (en) * 2002-07-27 2002-09-04 Astrazeneca Ab Novel compounds
DK1809624T3 (da) * 2004-08-28 2014-01-20 Astrazeneca Ab Pyrimidinsulfonamidderivater som kemokinreceptor-modulatorer
RU2011101661A (ru) * 2008-07-16 2012-08-27 Астразенека Аб (Se) Пиримидилсульфонамидное производное и его применение для лечения хемокин-опосредованных заболеваний

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE588170A (fr) * 1959-03-04 1960-09-01 Ici Ltd Composés hétérocycliques.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410793A (en) * 1940-03-01 1946-11-05 American Cyanamid Co Sulfonamido pyrimidines
GB866843A (en) * 1958-12-08 1961-05-03 Ici Ltd Sulphonamidopyrimidines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE588170A (fr) * 1959-03-04 1960-09-01 Ici Ltd Composés hétérocycliques.

Also Published As

Publication number Publication date
OA00944A (fr) 1968-03-22
BE618639A (fr) 1962-12-14
US3132139A (en) 1964-05-05
DK98960C (da) 1964-06-08
CH396008A (de) 1965-07-31
GB951026A (en) 1964-03-04
NL279406A (enrdf_load_html_response)

Similar Documents

Publication Publication Date Title
DE1218454B (de) Verfahren zur Herstellung von 4-Sulfanilamido-5, 6-dialkoxypyrimidinen
DE1023039B (de) Verfahren zur Herstellung von 5-Piperazino-pyridazon-(6)-verbindungen
DE1265758B (de) Verfahren zur Herstellung von o-(beta-Dialkylaminoaethoxy)-phenylketonen und deren Saeureadditionssalzen und quartaeren Salzen
DE1620381A1 (de) Derivate des 2-Aminopyrazins und Verfahren zu ihrer Herstellung
DE1795562B2 (de) N-Chlor-lNp-phenyHthiazoMamidin) Ausscheidung aus: 1470071
DE1470367A1 (de) Verfahren zur Herstellung von in 5-Stellung substituierten 5,6-Dihydro-6-oxopyrido[2,3-b][1,4]benzoxazepinen
CH474490A (de) Verfahren zur Herstellung neuer Benzolsulfonylharnstoffe
DE2637665A1 (de) 5-substituierte 5h-dibenz(b,f)azepin- derivate und verfahren zu deren herstellung
CH510044A (de) Verfahren zur Herstellung substituierter Amino-thiadiazole
DE1695667A1 (de) Neue Pyrrolderivate,deren Herstellung und deren Verwendung
DE342048C (de) Verfahren zur Herstellung hydrierter 2-Phenylchinolin-4-carbonsaeure, deren Homologeund Salzen dieser Saeuren
DE968212C (de) Verfahren zur Herstellung von Guanididen organischer Sulfosaeuren
DE890960C (de) Verfahren zur Herstellung eines aus einer aromatischen Stibinsaeure bestehenden Therapeuticums
DE1595875C (de) Phenothiazine und Verfahren zu deren Herstellung
CH507961A (de) Verfahren zur Herstellung von neuen antidiabetisch wirksamen Sulfonamiden
DE942027C (de) Verfahren zur Herstellung von substituierten 2-Iminothiazolidinen
DE1902651C3 (de) Neue Kortikoid-21-monophosphate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE736661C (de) Verfahren zur Herstellung von p-Acylaminobenzolsulfonsaeureamidverbindungen
DE2656604B2 (de) Verfahren zur Herstellung von 1 -(2-Tetrahydrofuryl)-5-fluor-uracil
DE1493567C3 (de) Ester von alpha-Alkylthyroxinderivaten und Verfahren zu ihrer Herstellung
DE2243665A1 (de) Verfahren zur herstellung von alpha(n-acyl)-aminosaeuren
DE573540C (de) Verfahren zur Herstellung von teilweise hydrierten Chinolinsulfonsaeuren
DE2103134C3 (de) 2-Aminoindazolo [1,2-b] phthalazin- 6-(11H), 13-dion, Verfahren zu dessen Herstellung sowie dieses enthaltende Arzneimittel
DE1131693B (de) Verfahren zur Herstellung von 18ª‰-Acetoxy-17ª‡-methoxy-16ª‰-methoxycarbonyl-2, 3-seco-3-oxo-20ª‡-yohimbanen
DE1161566B (de) Verfahren zur Herstellung von neuen, in 1-Stellungsubstituierten Lysergsäuren und Dihydrolysergsäuren.